PT  - JOURNAL ARTICLE
AU  - Luping Liu
AU  - Dongyang Zhang
AU  - Mai Johnson
AU  - Neal K. Devaraj
TI  - Light-activated tetrazines enable live-cell spatiotemporal control of bioorthogonal reactions
AID  - 10.1101/2020.12.01.405423
DP  - 2020 Jan 01
TA  - bioRxiv
PG  - 2020.12.01.405423
4099  - http://biorxiv.org/content/early/2020/12/02/2020.12.01.405423.short
4100  - http://biorxiv.org/content/early/2020/12/02/2020.12.01.405423.full
AB  - Bioorthogonal ligations encompass coupling chemistries that have considerable utility in living systems.1–3 Among the numerous bioorthogonal chemistries described to date, cycloaddition reactions between tetrazines and strained dienophiles are widely used in proteome, lipid, and glycan labeling due to their extremely rapid kinetics.4,5 In addition, a variety of functional groups can be released after the cycloaddition reaction,6,7 and drug delivery triggered by in vivo tetrazine ligation8 is in human phase I clinical trials.9 While applications of tetrazine ligations are growing in academia and industry, it has so far not been possible to control this chemistry to achieve the high degrees of spatial and temporal precision necessary for modifying mammalian cells with single-cell resolution. Here we demonstrate visible light-activated formation of tetrazines from photocaged dihydrotetrazines, which enables live-cell spatiotemporal control of rapid biorthogonal cycloaddition reactions between tetrazines and dienophiles such as trans-cyclooctenes (TCOs). Photocaged dihydrotetrazines are stable in conditions that normally degrade tetrazines, enabling efficient early-stage incorporation of bioorthogonal handles into biomolecules such as peptides. Photocaged dihydrotetrazines allow the use of non-toxic visible light to trigger tetrazine ligations on live mammalian cells. By tagging reactive phospholipids with fluorophores, we demonstrate modification of HeLa cell membranes with single-cell spatial resolution. Finally, we show that photo-triggered therapy is possible by coupling tetrazine photoactivation with strategies that uncage prodrugs in response to tetrazine ligation, opening up new methods for photopharmacology and precision drug delivery using bioorthogonal chemistry.Competing Interest StatementThe authors have declared no competing interest.